The miRNAs involved in prostate cancer chemotherapy response as chemoresistance and chemosensitivity predictors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The miRNAs involved in prostate cancer chemotherapy response as chemoresistance and chemosensitivity predictors

Published:2021-08-13 Issue:1 Volume:10 Page:51-71
ISSN:2047-2919
Container-title:Andrology
language:en
Short-container-title:Andrology

Author:

Konoshenko Maria¹^ORCID,Laktionov Pavel¹

Affiliation:

1. Institute of Chemical Biology and Fundamental Medicine Siberian Branch Russian Academy of Sciences Novosibirsk Russia

Publisher

Wiley

Subject

Urology,Endocrinology,Reproductive Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/andr.13086

Reference123 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Approval Summary

3. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

4. Taxol stabilizes microtubules in mouse fibroblast cells.

5. Clinical Pharmacokinetics of Docetaxel

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming chemoresistance and radio resistance in prostate cancer: The emergent role of non-coding RNAs;Pathology - Research and Practice;2024-03

2. From molecular mechanisms of prostate cancer to translational applications: based on multi-omics fusion analysis and intelligent medicine;Health Information Science and Systems;2023-12-18

3. Prostate cancer therapy outcome prediction: are miRNAs a suitable guide for therapeutic decisions?;Andrology;2023-09-26

4. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer;Pathology - Research and Practice;2023-08

5. Evidence-based procedures to improve the reliability of circulating miRNA biomarker assays;Clinical Chemistry and Laboratory Medicine (CCLM);2023-05-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3